This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Azevan Pharmaceuticals, Inc.. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2007
Title: The Innovative Contributions of Christophe D G Guillon
Introduction
Christophe D G Guillon is a notable inventor based in Bethlehem, PA, who has made significant contributions to the field of pharmaceuticals. With a focus on developing novel compounds, he has been instrumental in advancing treatments for various disease states.
Latest Patents
Guillon holds two patents that showcase his innovative work. His latest patents include novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives. These compounds are described for use in the treatment of disease states responsive to antagonism of the vasopressin V receptor.
Career Highlights
Guillon is currently associated with Azevan Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to developing effective treatments that address critical health issues.
Collaborations
Throughout his career, Guillon has collaborated with esteemed colleagues, including Robert F Bruns, Jr and Ned D Heindel. These partnerships have further enriched his research and innovation efforts.
Conclusion
Christophe D G Guillon's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile